Agfa HealthCare connects NWTPACS system for Northwest Territories Pristiq: new antidepressantWyeth is introducing Pristiq (desvenlafaxine 50 mg and 100 mg extended-release tablets) for the symptomatic relief of major depressive disorder in adults. New indication for Aclasta Novartis' Aclasta (zoledronic acid injection) is now approved for use as a once-yearly intravenous (IV) infusion in the prevention and treatment of corticosteroid-induced osteoporosis, to increase bone mineral density. CFP announces new president Peter Marshall has been appointed president of the Canadian Foundation for Pharmacy for 2009. Lax-A-Day: new PEG oral laxative PendoPharm/Pharmascience is introducing a new OTC osmotic laxative, Lax-A-Day (polyethylene glycol [PEG] 3350 powder for oral solution). BAD ADVICE: Psychiatrists, don't shrink from sudoku Ottawa hospital chief wins CMA president-elect nod PENSIONS: U.K. MDs special kind of self-employed YOUR TURN: The top medical absolutes PENSIONS: The European experience First Previous 2146 2147 2148 2149 2150 Next Last
